733 related articles for article (PubMed ID: 23108552)
1. Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
Pertwee RG
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3353-63. PubMed ID: 23108552
[TBL] [Abstract][Full Text] [Related]
2. Emerging strategies for exploiting cannabinoid receptor agonists as medicines.
Pertwee RG
Br J Pharmacol; 2009 Feb; 156(3):397-411. PubMed ID: 19226257
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Cristino L; Bisogno T; Di Marzo V
Nat Rev Neurol; 2020 Jan; 16(1):9-29. PubMed ID: 31831863
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids and Their Pharmacological Actions.
Pertwee RG
Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ⁹-THC.
Coskun ZM; Bolkent S
Cell Biochem Funct; 2014 Oct; 32(7):612-9. PubMed ID: 25187240
[TBL] [Abstract][Full Text] [Related]
7. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
Calik MW; Carley DW
Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
[TBL] [Abstract][Full Text] [Related]
8. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.
Pertwee RG
Addict Biol; 2008 Jun; 13(2):147-59. PubMed ID: 18482430
[TBL] [Abstract][Full Text] [Related]
9. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.
Cox ML; Haller VL; Welch SP
Eur J Pharmacol; 2007 Sep; 570(1-3):50-6. PubMed ID: 17588560
[TBL] [Abstract][Full Text] [Related]
10. The synthetic CB
Coronado-Álvarez A; Romero-Cordero K; Macías-Triana L; Tatum-Kuri A; Vera-Barrón A; Budde H; Machado S; Yamamoto T; Imperatori C; Murillo-Rodríguez E
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110301. PubMed ID: 33741446
[TBL] [Abstract][Full Text] [Related]
11. Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.
Valdeolivas S; Satta V; Pertwee RG; Fernández-Ruiz J; Sagredo O
ACS Chem Neurosci; 2012 May; 3(5):400-6. PubMed ID: 22860209
[TBL] [Abstract][Full Text] [Related]
12. Chromenopyrazoles: non-psychoactive and selective CB₁ cannabinoid agonists with peripheral antinociceptive properties.
Cumella J; Hernández-Folgado L; Girón R; Sánchez E; Morales P; Hurst DP; Gómez-Cañas M; Gómez-Ruiz M; Pinto DC; Goya P; Reggio PH; Martin MI; Fernández-Ruiz J; Silva AM; Jagerovic N
ChemMedChem; 2012 Mar; 7(3):452-63. PubMed ID: 22302767
[TBL] [Abstract][Full Text] [Related]
13. Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain.
Bagüés A; Martín MI; Sánchez-Robles EM
Eur J Pharmacol; 2014 Dec; 745():69-75. PubMed ID: 25446925
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoids and the Cardiovascular System in Health and Disease.
O'Sullivan SE
Handb Exp Pharmacol; 2015; 231():393-422. PubMed ID: 26408169
[TBL] [Abstract][Full Text] [Related]
15. Latest advances in cannabinoid receptor agonists.
Thakur GA; Tichkule R; Bajaj S; Makriyannis A
Expert Opin Ther Pat; 2009 Dec; 19(12):1647-73. PubMed ID: 19939187
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease.
Han QW; Yuan YH; Chen NH
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109745. PubMed ID: 31442553
[TBL] [Abstract][Full Text] [Related]
17. Delta-9-tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activation.
Wong H; Hossain S; Cairns BE
Eur J Pain; 2017 Nov; 21(10):1732-1742. PubMed ID: 28722246
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders.
Bisogno T; Di Marzo V
CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):564-73. PubMed ID: 20632970
[TBL] [Abstract][Full Text] [Related]
19. The pharmacology of cannabinoid receptors and their ligands: an overview.
Pertwee RG
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
[TBL] [Abstract][Full Text] [Related]
20. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
Anand P; Whiteside G; Fowler CJ; Hohmann AG
Brain Res Rev; 2009 Apr; 60(1):255-66. PubMed ID: 19150370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]